drugset / Trial / NCT00467844

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

NCT00467844

Phase 2 Completed 159 enrolled GTx
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to assess if Gtx-024 is effective in increasing lean body mass in subjects with muscle wasting related to cancer.

Timeline

Start
2007-05
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Enobosarm Small molecule 1 mg Oral
Subject Enobosarm Small molecule 3 mg Oral